Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Endovia Health Sciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q3 2022
- Shares held
- 2.28M
- +213.1K (+10.3%) vs. Q3 2022
- Total value
- $2.19M
- −$643.5K (−22.7%) vs. Q3 2022
- New holders
- 5
- 8 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 5 | $5 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 37 | $36 | 0.00% | +37 | New |
| Wells Fargo & Company | 196 | $188 | 0.00% | +21+12.0% | Added |
| Simplex Trading, LLC | 2,269 | $2.00K | 0.00% | −11,576−83.6% | Reduced |
| UBS Group AG | 8,006 | $7.69K | 0.00% | +7,195+887.2% | Added |
| Tower Research Capital LLC (TRC) | 9,090 | $9.00K | 0.00% | −6,510−41.7% | Reduced |
| Cutler Group LP | 10,360 | $9.00K | 0.00% | +10,360 | New |
| Bank of Montreal | 10,630 | $10.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,709 | $11.3K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 14,300 | $13.7K | 0.00% | +14,300 | New |
| Millennium Management LLC | 15,533 | $15.0K | 0.00% | +15,533 | New |
| Morgan Stanley | 16,852 | $16.2K | 0.00% | +4,651+38.1% | Added |
| Cambridge Investment Research Advisors, Inc. | 24,264 | $23.0K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 28,255 | $27.2K | 0.07% | +7,000+32.9% | Added |
| Parsons Capital Management Inc | 33,249 | $32.0K | 0.00% | −100,002−75.0% | Reduced |
| Virtu Financial LLC | 41,495 | $40.0K | 0.01% | −29,527−41.6% | Reduced |
| Northern Trust Corp | 42,618 | $41.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 62,409 | $60.0K | 0.00% | +1,340+2.2% | Added |
| State Street Corp | 70,000 | $67.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 79,573 | $76.5K | 0.00% | +79,573 | New |
| Bridgeway Capital Management, LLC | 102,300 | $98.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 214,529 | $206.2K | 0.00% | +135,209+170.5% | Added |
| Geode Capital Management, LLC | 223,120 | $214.0K | 0.00% | +8,621+4.0% | Added |
| Vanguard Group Inc | 1,257,887 | $1.21M | 0.00% | +122,482+10.8% | Added |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −30,044−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,343−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |